Biotest GmbH KGaA (LTS:0N6Z) Long-Term Debt: £0.00 Mil (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Biotest GmbH KGaA Long-Term Debt?

Biotest GmbH KGaA LTS:0N6Z Long-Term Debt is £0.00 Mil as of . 20.

Biotest GmbH KGaA's Long-Term Debt for the quarter that ended in . 20 was £0.00 Mil.

Biotest GmbH KGaA  (LTS:0N6Z) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Biotest GmbH KGaA Long-Term Debt Related Terms

Biotest GmbH KGaA Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Biotest GmbH KGaA's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biotest GmbH KGaA Long-Term Debt Chart

Biotest GmbH KGaA Annual Data
Trend
Long-Term Debt

Biotest GmbH KGaA Semi-Annual Data
Long-Term Debt
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of £0.00 Mil mean?
Biotest GmbH KGaA (LTS:0N6Z) has a Long-Term Debt of £0.00 Mil as of . 20.
Is Biotest GmbH KGaA's Long-Term Debt too high?
Biotest GmbH KGaA's current Long-Term Debt is £0.00 Mil.
How does Biotest GmbH KGaA's Long-Term Debt compare to ?
Biotest GmbH KGaA's Long-Term Debt of £0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Biotechnology company?
A good Long-Term Debt depends on the Biotechnology industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Biotest GmbH KGaA's current Long-Term Debt is £0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biotest GmbH KGaA stock overvalued right now?
Biotest GmbH KGaA (LTS:0N6Z) has a current Long-Term Debt of £0.00 Mil. The current Long-Term Debt is £0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Biotest GmbH KGaA (LTS:0N6Z), the current Long-Term Debt is £0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biotest GmbH KGaA Business Description

Comparable Companies
Biotest GmbH & Co KGaA is a specialist in haematology, clinical immunology, and intensive care medicine. The group develops, manufactures, and markets plasma proteins and biotherapeutic drugs. The group's value chain extends from pre-clinical and clinical development to world-wide marketing and distribution. It manufactures immunoglobulins, clotting factors, and albumins, which are derived from human blood plasma. The group markets its products in Europe, the Middle East, China, Australia, Africa, and the USA.